Question special
Lead Moderator

Are there particular patients who would not see a survival benefit with an HLA-incompatible live donor? For example, do you propose transplanting HLA-incompatible kidneys into patients with high panel-reactive antibodies, or should these patients continue to wait for organs that are better matched for their immune systems?